AC Immune develops treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's, based in Lausanne, Switzerland. It last closed at $2.11 on Nov 17, up 0.96% on the day.
From ACIU's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 13). Last 12 months adds up the four latest quarters. Figures are in CHF. Per share figures are left out because the US listing can represent a different number of shares.
Only 1 firm rated ACIU in the past 90 days, not enough for a consensus
Average 12-month target
$8.00
▲ 279.1% upside
Based on 1 analyst who set a price target on ACIU in the past 90 days. The average target is $8.00, with a high of $8.00 and a low of $8.00, compared with the last close of $2.11.
Low $8.00Avg $8.00High $8.00
Blue marker: last close $2.11
Highest target$8.00
Average target$8.00
Lowest target$8.00
Latest rating changes
BTIGReiterated
Aug 20Buy$8
Date
Firm
Action
Rating
Price target
Aug 20
BTIG
Reiterated
Buy
$8
Loading…
Technical Analysis
ACIU · as of the Nov 17 close · updated after every close
Downtrend
The stock is 7% below its 20 day and 17% below its 50 day average. It is 26% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 41). The nearest support is the swing low (Jun 9) at $2.10, and the nearest resistance the Pivot R1 at $2.15.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 6.9%/day
Key levels
$3.9052 week high+84.8%
$2.65200 day average+25.6%
$2.48100 day average+17.5%
$2.4750 day average+17.1%
$2.34Swing high (Jul 22)+10.9%
$2.2620 day average+7.1%
$2.15Pivot R1+1.9%
$2.11Last close
$2.10Swing low (Jun 9)−0.5%
$2.09Pivot−0.9%
$2.05Pivot S1−2.8%
$2.0252 week low−4.3%
Indicators
RSI (14)
41.33
Middle of its range
Neutral
MACD
-0.09
Below its signal line
Bearish
Stochastic
18.3
Near the bottom of its range
Oversold
ADX (14)
19.7
No clear trend
Williams %R
-81.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-98.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.0%
Change over 10 sessions
Bullish
ATR (14)
$0.15
Typical daily range, 6.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 15.4%/day
Key levels
$3.9052 week high+84.8%
$2.65200 day average+25.6%
$2.48100 day average+17.5%
$2.4750 day average+17.1%
$2.34Swing high (Jul 22)+10.9%
$2.2620 day average+7.1%
$2.15Pivot R1+1.9%
$2.11Last close
$2.10Swing low (Jun 9)−0.5%
$2.09Pivot−0.9%
$2.05Pivot S1−2.8%
$2.0252 week low−4.3%
Indicators
RSI (14)
39.44
Weak, oversold below 30
Neutral
MACD
-0.13
Below its signal line
Bearish
Stochastic
14.4
Near the bottom of its range
Oversold
ADX (14)
14.5
No clear trend
Williams %R
-90.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-127.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−23.6%
Change over 10 sessions
Bearish
ATR (14)
$0.33
Typical daily range, 15.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ACIU
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ACIU did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ACIU usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ACIU has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2016.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ACIU is in one of them and how their past ACIU trades turned out.
AC Immune is a biopharmaceutical company based in Lausanne, Switzerland, that develops treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Its candidates include active immunotherapies, which are biologic treatments, and small molecule drugs designed to act inside brain cells. The company uses its own technology platforms to design these candidates and has partnered with large global pharmaceutical companies on parts of its pipeline.